|
|
|
MESOTHELIOMA NEWS - CONTINUED
- Gene Signature Could Revolutionize Cancer Care
Discovery should help doctors tailor treatment to specific tumor type, June 2, 2005 - Cancer seen in family members of asbestos workers
People who were exposed to asbestos through a family member who worked with the material appear to run the risk of developing mesothelioma, May 30, 2005 - Vitamin E helps battle mesothelioma
Alpha-TOS, which is closely related to Vitamin E, killed mesothelioma cancer cells in experiments with mice, May 22, 2005 - Ex-'silver bullet' re-aimed at cancer
Formerly hyped anti-angiogenesis drugs that starve tumors show new promise in use with chemotherapy, May 16, 2005 - SV40 not implicated in mesothelioma
Researchers eliminated contamination that has likely been the reason previous studies have implicated SV40, April 6, 2005 - New treatment options for some difficult cancers improve
survival and quality of life
Surgery combined with inserting heated chemotherapy drugs directly into the abdomen can improve survival rates, March 7, 2005 - Woman Diagnosed With Mesothelioma Gets New Results
Karen Grant's treatment seems to have had positive results. January 7, 2005 - Coramsine offers hope to mesothelioma patients
Researchers excited about new chemotherapy drug coramsine. November 25, 2004
- Coramsine reported effective in treating and preventing mesothelioma
in a mouse model of the cancer
Australia's Solbec Shares Soar After Cancer Drug Find. November 23, 2004, coramsine - No Role For Simian Virus 40 In Human Pleural Mesotheliomas
Researchers at Memorial Sloan-Kettering Cancer Center found no evidence for a significant role for SV40 in human mesotheliomas
- Experimental Surgery Gives Cancer Patient Hope
Very aggressive combination of surgery and chemotheraphy. September, 2004 - Studies Find No Evidence That SV40 is Related to Human Cancer
Further evidence that exposure to simian virus 40 (SV40) is not associated with mesothelioma in humans. August, 2004 - SBP002 Boosts the Immune System
Press Release from Solbec. June, 2004 - Celebrex Hits Mesothelioma, in Lab Studies
COX-2 inhibitor has an effect on malignant mesothelioma. May 6, 2004 - Group Launches Asbestos-Cancer Study
Karmanos Cancer Center to start new program, April 5, 2004 - New Study Reviews Novel Approach to Control Inflammation Using
Melanocortin Receptors
Press Release from Zengen, March 3, 2004 - FDA Approves Alimta-Cisplatin Combination for Treatment of
Asbestos-Related Cancer Mesothelioma
Press Release from Eli Lilly, February 5, 2004 - FDA Approves First Drug for Rare Type of Cancer
FDA News: FDA approves Alimta for use in the treatment of patients with malignant pleural mesothelioma, February 5, 2004 - Mesothelioma Cancer drug developed by chemistry professor
Princeton University chemist's discovery of Alimta - a cancer drug with tremendous potential for treating solid tumors, February, 2004 - First-ever Blood Test for Mesothelioma Being Developed
Asbestos Cancer Breakthrough Reported by Pacific Northwest Research Institute, November 13, 2003 - New Directions for the Treatment of Mesothelioma
An Expert Interview With Nicholas J. Vogelzang, MD, June 9, 2003 - FDG-PET May Have Prognostic Value in Malignant Pleural Mesothelioma
Report from ASCO 39th Annual Meeting, June 2, 2003 - Novel RAF Kinase Inhibitor Bay 43-9006 Shows Early Signs
of Tolerability and Activity
Press Release from Bayer Pharmaceuticals and Onyx Pharmaceuticals, June 2, 2003 - Next Era of Cancer Therapy Aims to Separate Cancer From Blood
Supply
News from M.D. Anderson Cancer Center, May 16, 2003
